Advertisement

Table of Contents

September 01, 1986; Volume 30,Issue 3

You have access
Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstem.
D D Flynn and L T Potter

Molecular Pharmacology September 1986, 30 (3) 193-199;
You have access
Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
T K Harden, M M Heng and J H Brown

Molecular Pharmacology September 1986, 30 (3) 200-206;
You have access
Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
M McKinney and E Richelson

Molecular Pharmacology September 1986, 30 (3) 207-211;
You have access
Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
R S Chang, V J Lotti, T B Chen and K A Kunkel

Molecular Pharmacology September 1986, 30 (3) 212-217;
You have access
Modulation of the chloride ionophore by benzodiazepine receptor ligands: influence of gamma-aminobutyric acid and ligand efficacy.
K W Gee, L J Lawrence and H I Yamamura

Molecular Pharmacology September 1986, 30 (3) 218-225;
You have access
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
G J Kilpatrick, N el Tayar, H Van de Waterbeemd, P Jenner, B Testa and C D Marsden

Molecular Pharmacology September 1986, 30 (3) 226-234;
You have access
Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
S Mong, G Chi-Rosso, J Miller, K Hoffman, K A Razgaitis, P Bender and S T Crooke

Molecular Pharmacology September 1986, 30 (3) 235-242;
You have access
Association of a spin-labeled local anesthetic with the allosterically coupled noncompetitive inhibitor site on the acetylcholine receptor.
A Palma, J M Herz, H H Wang and P Taylor

Molecular Pharmacology September 1986, 30 (3) 243-251;
You have access
[3H]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles.
J A Near

Molecular Pharmacology September 1986, 30 (3) 252-257;
You have access
Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
A M Johansson, A Karlén, C J Grol, S Sundell, L Kenne and U Hacksell

Molecular Pharmacology September 1986, 30 (3) 258-269;
You have access
Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies.
L Rumbach, C Mutet, G Cremel, C A Marescaux, G Micheletti, J M Warter and A Waksman

Molecular Pharmacology September 1986, 30 (3) 270-273;
You have access
Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts.
S C Tsai, R Adamik, B E Hom, V C Manganiello and J Moss

Molecular Pharmacology September 1986, 30 (3) 274-278;
You have access
A theoretical study of the comparative binding affinities of daunomycin derivatives to a double-stranded oligomeric DNA. Proposal for new high affinity derivatives.
K X Chen, N Gresh and B Pullman

Molecular Pharmacology September 1986, 30 (3) 279-286;
You have access
Oxidation of quinidine by human liver cytochrome P-450.
F P Guengerich, D Müller-Enoch and I A Blair

Molecular Pharmacology September 1986, 30 (3) 287-295;
You have access
The cytochrome P-450 monooxygenase system of rabbit lung enzyme components, activities, and induction in the nonciliated bronchiolar epithelial (Clara) cell, alveolar type II cell, and alveolar macrophage.
B A Domin, T R Devereux and R M Philpot

Molecular Pharmacology September 1986, 30 (3) 296-303;